S. 2917 — Engrossed in Senate

113th CONGRESS 2d Session S. 2917 AN ACT To expand the program of priority review to encourage treatments for tropical diseases. 1. Short title This Act may be cited as the Adding Ebola to the FDA Priority Review Voucher Program Act. 2. Priority review to encourage treatments for tropical diseases Section 524 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n) is amended— (1) in subsection (a)(3)— (A) by redesignating subparagraph (Q) as subparagraph (R); (B) by inserting after subparagraph (P) the following: (Q) Filoviruses. ; and (C) in subparagraph (R), as so redesignated, by striking regulation by and inserting order of; and (2) in subsection (b)— (A) in paragraph (2), by adding There is no limit on the number of times a priority review voucher may be transferred before such voucher is used. after the period at the end; and (B) in paragraph (4), by striking 365 days and inserting 90 days. Passed the Senate December 2, 2014.Secretary